L. Fredrik Jarskog

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

Diana O. Perkins, Clark Jeffries, L. Fredrik Jarskog et al. · Genome biology · 2007 · 565 citations · Full text

Life Sciences, Molecular Biology, Psychiatry +17

Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain

Ari Urakubo, L. Fredrik Jarskog, Jeffrey A. Lieberman et al. · Schizophrenia Research · 2001 · 405 citations

Life Sciences, Immunology, Obstetrics +17

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial

Karen E. Anderson, David Stamler, Mat D. Davis et al. · The Lancet Psychiatry · 2017 · 335 citations

Medicine, Neurology, Pharmacotherapy +9

Randomized controlled trial of deutetrabenazine for tardive dyskinesia

Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser et al. · Neurology · 2017 · 328 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia

Cort A. Pedersen, Clare M. Gibson, Shane W. Rau et al. · Schizophrenia Research · 2011 · 306 citations

Medicine, Pharmacology, Psychiatry +14